$4.85
0.081.68%
Últ. Act.: Oct 21, 7:25 PM
$4.88
0.112.31%
Nuvation Bio (NUVB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.13 | $0.06 | $-0.07 | $-0.16 |
| Actual | $-0.18 | $0.01 | $-0.11 | $-0.16 |
| Surprise | -38.5% | -83.3% | -57.1% | 0.00% |
| Revenue | ||||
| Estimate | $27.5M | $68.4M | $33.5M | $6.8M |
| Actual | $31.7M | $83.2M | $41.9M | $13.1M |
| Surprise | +15.0% | +21.6% | +25.1% | +92.9% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.11 | $-0.09 | $-0.02 | $-0.06 |
| Revenue | ||||
| Consensus | $34.8M | $45.4M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.18 | $-0.13 | -38.5 % |
| Q1 | May 4, 2026 | $0.01 | $0.06 | -83.3 % |
| Q4 | Mar 2, 2026 | $-0.11 | $-0.07 | -57.1 % |
| Q3 | Nov 3, 2025 | $-0.16 | $-0.16 | 0.00 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $31.69M | $27.54M | 15.0 % |
| Q1 | May 4, 2026 | $83.23M | $68.43M | 21.6 % |
| Q4 | Mar 2, 2026 | $41.87M | $33.47M | 25.1 % |
| Q3 | Nov 3, 2025 | $13.12M | $6.80M | 92.9 % |